Oxytocin: Regulatory Status
Current legal and regulatory status for Oxytocin across jurisdictions. This page reflects the most recent verified information and is updated as regulatory actions occur.
Back to Oxytocin overviewUnited States
FDA Approved
Prescription required
FDA-approved as Pitocin (labor induction and augmentation, 1980); Pitocin (postpartum hemorrhage control, 1980); Syntocinon (intranasal (lactation support — discontinued in US), null). Compounding status: available through compounding pharmacies (intranasal, sublingual formulations). WADA: not listed. approved globally for obstetric indications; intranasal formulations available in some countries for lactation support
What This Means
Reclassification is not the same as FDA approval.
Even if Oxytocin moves to Category 1, it remains an off-label therapeutic that requires physician supervision. Category 1 means it can be compounded under section 503A — it does not confer approved-drug status.